Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
Source
Cancer immunology and immunotherapy - ISSN 0340-7004-72:2 (2023) p. 475-491
The evolution and prognostic role of tumour-infiltrating lymphocytes and peripheral blood-based biomarkers in inflammatory breast cancer patients treated with neoadjuvant chemotherapy
Source
Cancers - ISSN 2072-6694-13:18 (2021) p.
Targeting the PD-1 axis with pembrolizumab for recurrent or metastatic cancer of the uterine cervix : a brief update
Source
International journal of molecular sciences - ISSN 1422-0067-22:4 (2021) p.
The non-bone-related role of RANK/RANKL signaling in cancer
Source
Advances in experimental medicine and biology - ISSN 0065-2598-1277 (2020) p. 53-62
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer
Source
The Breast - ISSN 0960-9776-53 (2020) p. 212-220